BeiGene Announces Closing of Its RMB22.2 Billion (US$3.5 Billion) Initial Public Offering on the STAR Market of the Shanghai Stock Exchange in China
RMB Shares begin trading on the STAR Market under the stock code “688235”, making BeiGene the first triple-listed biotech company on NASDAQ, Hong Kong Stock Exchange, and STAR Market CAMBRIDGE, […]